MedWell Laboratories Overview

  • Year Founded
  • 2009

Year Founded

  • Status
  • Out of Business

  • Latest Deal Type
  • Out of Business

MedWell Laboratories General Information

Description

Developer of non-steroidal anti-inflammatory drugs. The company develops non-steroidal anti-inflammatory drugs for treatment of mild to moderate chronic inflammatory disorders. It develops drug which are effective and safe due to the mechanism of action as cyclooxygenase 2 (COX-2) and 5-Lipoxygenase (5-LOX) enzymes dual inhibition.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly Accelerator/Incubator backed
Primary Industry
Pharmaceuticals
Other Industries
Other Pharmaceuticals and Biotechnology
Corporate Office
  • Nazareth Industrial Area
  • P.O. Box 2252
  • Nazareth 16000
  • Israel

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

MedWell Laboratories Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Out of Business 01-Oct-2017 Completed Out of Business
1. Accelerator/Incubator Completed Startup
To view MedWell Laboratories’s complete valuation and funding history, request access »

MedWell Laboratories Patents

MedWell Laboratories Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-3148530-A1 Methods for treating multiple sclerosis Inactive 25-May-2014 0000000000
US-20170196987-A1 Methods for treating multiple sclerosis Inactive 25-May-2014
EP-3004878-A1 Skin care products comprising substituted hydroxyproline with unsaturated fatty acids derivatives Inactive 28-May-2013 00000000000
US-20160113904-A1 Skin care products comprising substituted hydroxyproline with unsaturated fatty acids derivatives Inactive 28-May-2013 00000000000
CA-2810468-A1 Conjugates of polyunsaturated fatty acids and amine-containing compounds and uses thereof Inactive 06-Sep-2010 A61K9/0014
To view MedWell Laboratories’s complete patent history, request access »

MedWell Laboratories Executive Team (2)

Name Title Board Seat Contact Info
Michal Olshansky Chief Executive Officer
Taher Nassar Ph.D Co-Founder, Inventor, Board Member & Chief Scientist
To view MedWell Laboratories’s complete executive team members history, request access »

MedWell Laboratories Board Members (3)

Name Representing Role Since
Oren Fuerst Ph.D Self Board Member 000 0000
Sheila Oren MD MedWell Laboratories Board Member 000 0000
You’re viewing 2 of 3 board members. Get the full list »

MedWell Laboratories FAQs

  • When was MedWell Laboratories founded?

    MedWell Laboratories was founded in 2009.

  • Who is the founder of MedWell Laboratories?

    Taher Nassar Ph.D is the founder of MedWell Laboratories.

  • Who is the CEO of MedWell Laboratories?

    Michal Olshansky is the CEO of MedWell Laboratories.

  • Where is MedWell Laboratories headquartered?

    MedWell Laboratories is headquartered in Nazareth, Israel.

  • What industry is MedWell Laboratories in?

    MedWell Laboratories’s primary industry is Pharmaceuticals.

  • Is MedWell Laboratories a private or public company?

    MedWell Laboratories is a Private company.

  • What is MedWell Laboratories’s current revenue?

    The current revenue for MedWell Laboratories is 000000.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »